New York, May 12, 2016 -- Moody's Investors Service, ("Moody's") today assigned a Ba2 (LGD 4) rating to LifePoint Health, Inc.'s proposed senior unsecured bonds due 2024. Moody's understands that the proceeds of the new notes will be used to redeem the company's existing $400 million 6.625% senior notes due 2020. There are no changes to LifePoint's existing ratings, including the Ba2 Corporate Family Rating and Ba2-PD Probability of Default Rating. The rating outlook is stable.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.